YMC Announces Formal Study of Large-Scale Production of Specialty Peptide Drug API with Continuous Chromatography System
PeptiDream and YMC groups announce a formal joint-task group to scale successful lab work to multiple GMP production lines for specialty peptide drug products at the main factory of PeptiStar Inc. YMC’s patented twin-column technology will be a key technology in the venture. Work is anticipated to result in the implementation of the technology on a large scale in late 2021.
View full press release